Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Liqiang Deng
Institutions:
Guangzhou University of Chinese Medicine,
Chenzhou First People's Hospital,
First Affiliated Hospital of Jinan University
Observed institutions:
Guangzhou University of Chinese Medicine,
Chenzhou First People's Hospital,
Shandong Maternal and Child Health Hospital,
First Affiliated Hospital of Jinan University,
Southern Medical University
ORCID:
0000-0002-2112-7129
Observed ORCID:
0000-0002-2112-7129
OpenAlex ID:
A5103077735
RNA N6-methyladenosine modification is required for miR-98/MYCN axis-mediated inhibition of neuroblastoma progression
2020
·
Junmei Cheng
, Lingling Xu
, et al.
·
Scientific Reports
·
28
PDF
MicroRNA-613 Enhances Nasopharyngeal Carcinoma Cell Radiosensitivity via the DNA Methyltransferase 3B/Tissue Inhibitor of Matrix Metalloproteinase-3/Signal Transducer and Activator of Transcription-1/Forkhead Box O-1 Axis
2022
·
Liqiang Deng
, Qing Yin
, et al.
·
Disease Markers
·
10
PDF
LncRNA HOTTIP facilitated tumor growth via stimulating the hnRNPA2B1/DKK1/Wnt/β-catenin regulatory axis in hepatocellular carcinoma
2023
·
Weiqiang Zeng
, Chuanjian Shi
, et al.
·
Genes & Diseases
·
8
FOXP1 exacerbates allergic rhinitis progression by mediating ferroptosis in nasal mucosal epithelial cells via transcriptional regulation of SDHAF2
2026
·
Liqiang Deng
, Debao Luo
, et al.
·
Inflammation Research
[Shengmai San improves osimertinib resistance of non-small cell lung cancer cells by regulating the lactate/Wnt/β-catenin/LDHA pathway].
2026
·
Zhiqing Liang
, Fuzhen Pan
, et al.
·
PubMed
Dexmedetomidine Inhibits Acute Lung Injury by Upregulating miR-144 Expression in Mice
2021
·
Liqiang Deng
, Min Zhao
, et al.
·
Journal of Biomaterials and Tissue Engineering
Show more works
View as search
Works count:
6
Citation count:
45
H-index:
3
I10-index:
2
Year
Topic
Type